NEW YORK (GenomeWeb News) – Vanderbilt University said that it has been awarded a cooperative agreement for up to $16.5 million to develop mass spectrometry-based methods to determine the effect of toxic agents on human cells.

The award for up to five years is an agreement with the Defense Advanced Research Projects Agency and the Army Research Office, and is one of three recently awarded through DARPA's Rapid Threat Assessment program. The other two awards went to the University of Colorado, Boulder, and George Washington University.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.

Mar
05
Sponsored by
SomaLogic

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.